Intrinsic Value of S&P & Nasdaq Contact Us

Stereotaxis, Inc. STXS AMEX

American Stock Excha • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.00
+97%

Stereotaxis, Inc. (STXS) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is bullish — 10 Buy.

The consensus price target is $4.00, representing an upside of 97% from the current price $2.03.

Analysts estimate Earnings Per Share (EPS) of $-0.27 and revenue of $0.03B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.30 vs est $-0.27 (missed -12.1%). 2025: actual $-0.25 vs est $-0.24 (missed -3.8%). Analyst accuracy: 93%.

STXS Stock — 12-Month Price Forecast

$4.00
▲ +97.04% Upside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for Stereotaxis, Inc., the price target is $4.00.
The average price target represents a +97.04% change from the last price of $2.03.

STXS Analyst Ratings

Buy
10
Ratings
10 Buy
Based on 10 analysts giving stock ratings to Stereotaxis, Inc. in the past 3 months
Rating breakdown
Buy
10 100%
100%
Buy
10 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — STXS

93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.30 vs Est –$0.27 ▼ 10.8% off
2025 Actual –$0.25 vs Est –$0.24 ▼ 3.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — STXS

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.027B vs Est $0.027B ▼ 1.1% off
2025 Actual $0.032B vs Est $0.033B ▼ 1.2% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message